Factors Affecting Waiting Times for Opioid Treatment
Author Information
Author(s): Nkemjika Stanley MD, MPH, Oforeh Kenneth MD, Olwit Connie PhD, MSN, Olayinka Olaniyi MD, MPH, Tumenta Terence MD, MPH
Primary Institution: Thomas Jefferson University
Hypothesis
Biological sex has a moderating effect on opioid use disorder treatment accessibility.
Conclusion
Both females and males who received medications for opioid use disorder had lower odds of waiting more than 7 days to enter treatment than those who received no medications.
Supporting Evidence
- Medications for opioid use disorder use among males was significantly different, with waiting times varying based on treatment type.
- Females reported higher rates of medical comorbidity and substance cravings compared to males.
- Longer wait times are linked to worse outcomes, such as higher chances of overdosing and relapsing.
Takeaway
This study looks at how long people wait to get treatment for opioid use disorder and finds that men and women wait different amounts of time based on various factors.
Methodology
The study used a national sample from the 2018 Treatment Episode Data Set Discharge, analyzing waiting times and treatment accessibility through logistic regression.
Potential Biases
Potential bias due to self-reported data and the cross-sectional design.
Limitations
The cross-sectional nature of the data limits causal inferences, and the reliance on self-reported data may introduce bias.
Participant Demographics
Participants were primarily aged 25-49, with a majority being non-Hispanic White, and included both males and females with varying educational and employment statuses.
Statistical Information
P-Value
<0.05
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website